Medtronic most likely to challenge Intuitive Surgical in robot-assisted surgery

medtronic-intuitive-1x1-150x150Medtronic (NYSE:MDT) is the most likely rival to Intuitive Surgical‘s (NSDQ:ISRG) dominance in the robot-assisted surgery space, but is still at least a year away from putting a competing device on the market, according to 1 analyst covering the medical device industry.

Sunnyvale, Calif.-based Intuitive has a long lead, having had its flagship da Vinci system since 2002 and is still on a roll, introducing new systems and instruments and looking to expand into more surgical areas. Despite Medtronic and a spate of other potential entrants, “we remain of the mindset that it will be tough to derail da Vinci,” Newitter wrote from the annual meeting of the Society of American Gastrointestinal & Endoscopic Surgeons in Boston.

READ THE REST HERE

About Peter Coffaro 1102 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


*